iiinova — where your digital self keeps evolving

FluiDx-AD @fluidx-ad.bsky.social · 20/09/2026

🔬 During #WorldAlzheimersMonth and every day, #Alzheimer’s research moves forward, & the diagnostic journey must also. ❓ How can we make #diagnosis more personalised, timely and useful? Learn about saliva-& blood-based diagnostic tools that could provide earlier answers & better #care: fluidx-ad.eu

000

FluiDx-AD @fluidx-ad.bsky.social · 18/09/2026

This week, #WorldPatientSafetyDay highlighted safer healthcare for all. 🔬 @fluidx-ad.bsky.social is developing a simpler, less invasive way to detect #Alzheimer’s with blood & saliva for earlier #diagnosis & more accessible, patient-centred care. ➡️ www.fluidx-ad.eu @who.int #dementia #research

fluidx-ad.eu

Home - FluidX-ad

FluiDx-AD is a collaborative Horizon Europe-funded project aimed at improving Alzheimer’s disease diagnosis and management.

011

FluiDx-AD @fluidx-ad.bsky.social · 29/06/2026

📢 The second edition of the @fluidx-ad.bsky.social newsletter is out! Discover our latest project updates, upcoming events and interviews with Marte Sødal and Lukas Gemein. 📖 Read it here: mailchi.mp/2275605c3562...

000

FluiDx-AD @fluidx-ad.bsky.social · 15/06/2026

📢 New FluiDx-AD project flyer now available! The flyer was distributed at the Pre Diagnostics booth during the Healthtech Festival 2026 in Oslo last week. Many thanks to Pre Diagnostics for supporting its visibility 🙏 ➡️https://www.fluidx-ad.eu/project-flyer-successfully-developed/

000

FluiDx-AD @fluidx-ad.bsky.social · 04/06/2026

📢 The FluiDx-AD General Assembly took place yesterday and brought together partners from across Europe to review progress, exchange insights and align on the next steps. Having successfully completed our first periodic report, we have now entered Reporting Period 2. www.fluidx-ad.eu/fluidx-ad-co...

000

FluiDx-AD @fluidx-ad.bsky.social · 15/05/2026

Project Coordinator Ira Haraldsen makes the care problem clear: long waits can mean missed opportunities. @fluidx-ad.bsky.social is developing saliva- and blood-based tests intended to make Alzheimer's diagnosis faster and more accessible. For more information, visit our website: fluidx-ad.eu/

000

Reposted by FluiDx-AD

Alzheimer Europe @alzheimereurope.bsky.social · 31/03/2026

Check out our March 2026 #dementia newsletter, with updates from across Europe and beyond! bit.ly/AE-newslette...

042

FluiDx-AD @fluidx-ad.bsky.social · 20/03/2026

“An early diagnosis can help people and families access the right support sooner.” For #BrainAwarenessWeek, discover how FluiDx-AD is working on saliva- and blood-based biomarker tests for Alzheimer’s disease. #BAW2026 #BrainAwarenessWeek2026

000

FluiDx-AD @fluidx-ad.bsky.social · 19/03/2026

For Brain Awareness Week, why does early diagnosis matter? “Being able to obtain an early diagnosis would enable families, and carer members in particular, to plan ahead for lifestyle changes, consider support that will inevitably be needed and hopefully avoid too many crises.” #BrainAwarenessWeek

000

FluiDx-AD @fluidx-ad.bsky.social · 18/03/2026

Our first #FluiDxAD newsletter is out @fluidx-ad.bsky.social, funded by Horizon Europe, is developing minimally invasive saliva- and blood-based tests to support earlier diagnosis & management of Alzheimer’s disease. Read: mailchi.mp/42c58952021c... Subscribe: eepurl.com/i-L--U #BrainAwarenessWeek

011

FluiDx-AD @fluidx-ad.bsky.social · 17/03/2026

FluiDx-AD is a Horizon Europe project developing saliva- & blood-based tests for earlier Alzheimer’s disease diagnosis and better access to next-generation treatments. Watch our interview with Vebjørn Andersson from Oslo University Hospital: vimeo.com/1170223264?s... #BrainAwarenessWeek2026 #BAW2026

vimeo.com

Interview with Vebjørn Anderson about the FluiDx-AD project

Welcome to the FluiDx-AD project! FluiDx-AD is a collaborative Horizon Europe-funded project aimed at improving Alzheimer’s disease diagnosis and management.…

011

FluiDx-AD @fluidx-ad.bsky.social · 16/03/2026

It's #BrainAwarenessWeek! By developing innovative saliva- and blood-based diagnostic tests, we strive to improve early detection, facilitate access to next-generation treatments and to enhance the quality of life for millions affected by #Alzheimer’s disease. vimeo.com/1058971988?f...

vimeo.com

FluiDx-AD - A novel test trio to detect peptide biomarkers in saliva and blood for enhanced diagnosis and management of AD

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither…

022

Reposted by FluiDx-AD

Alzheimer Europe @alzheimereurope.bsky.social · 11/03/2026

France supported by 9 other Member States is asking the European Commission to reintroduce operating grants to the EU health programme The abolition of these grants has impacted the ability of associations to give a voice to patients in EU policies #EU4Health www.alzheimer-europe.org/news/french-...

alzheimer-europe.org

French Government leads on non-paper to reinstate operating grants for health NGOs

The French Government has led on the submission of a non-paper, along with 12 other Member States, calling on the European Commission to reconsider it

032

Reposted by FluiDx-AD

Alzheimer Europe @alzheimereurope.bsky.social · 04/03/2026

📰 Our February newsletter is out today, with #dementia news from across Europe and beyond... ! Download it, here: bit.ly/AE-newslette... And just in case you missed the January edition, check it out here: bit.ly/AE-newslette...

043

FluiDx-AD @fluidx-ad.bsky.social · 04/03/2026

Have a read of the latest @alzheimereurope.bsky.social newsletter, covering how the members of #H2020 @fluidx-ad.bsky.social project's Advisory Board participated in a consultation about findings from a systematic review & its communication to the public: www.alzheimer-europe.org/sites/defaul...

alzheimer-europe.org

030

FluiDx-AD @fluidx-ad.bsky.social · 09/02/2026

Members of the @fluidx-ad.bsky.social Advisory Board consult about findings from systematic review about the effects of diagnosing Alzheimer's disease via fluid-based biomarker tests. Thanks for their feedback & the engaged discussion! www.fluidx-ad.eu/fluidx-ad-co... @alzheimereurope.bsky.social

033

FluiDx-AD @fluidx-ad.bsky.social · 08/12/2025

Members of the @fluidx-ad.bsky.social projects' Advisory Board held their first online meeting. FluiDx-AD is a collaborative project aimed at improving Alzheimer’s disease diagnosis & management through the development of innovative saliva and blood-based tests. www.fluidx-ad.eu/members-of-t...

fluidx-ad.eu

Members of the FluiDx-AD Public Advisory Board meet online - FluiDx-AD

FluiDx-AD is a collaborative project aimed at improving Alzheimer’s disease (AD) diagnosis and management through the development of innovative saliva and blood-based diagnostic tests. These tests wil...

010

FluiDx-AD @fluidx-ad.bsky.social · 27/11/2025

Yesterday, project partners Faye Forsyth & @chrisbintener.bsky.social met with members of @alzheimereurope.bsky.social European Working Group of People with Dementia to discuss how to implement feedback on a saliva sample collection procedure to screen for #Alzheimer’s disease biomarkers. #EWGPWD

032

Reposted by FluiDx-AD

ChrisBintener @chrisbintener.bsky.social · 20/11/2025

Today, Faye Forsyth & I met Praveen Sharma to discuss feedback from EWGPWD and EDCWG on a device to detect Alzheimer’s disease biomarkers in saliva. Next week we’ll focus on how to communicate test results with potential future users: fluidx-ad.eu

021

FluiDx-AD @fluidx-ad.bsky.social · 03/11/2025

Have a read of @alzheimereurope.bsky.social newsletter, featuring the first #H2020 @fluidx-ad.bsky.social General Assembly & a consultation with the European Working Group of People with Dementia & European Dementia Carers Working Group on a saliva prototype for Alzheimer’s disease biomarkers.

020

FluiDx-AD @fluidx-ad.bsky.social · 20/10/2025

HemoDx, is developing a saliva collection device that could enable cheaper and easier screening for #Alzheimer’s disease. Together with @alzheimereurope.bsky.social, people affected by dementia provided feedback through structured Public Involvement consultations. www.fluidx-ad.eu/fluidx-ad-co...

fluidx-ad.eu

FluiDx-AD consults with people affected by dementia to improve screening test - FluiDx-AD

Background HemoDx, a Norwegian company, have developed a saliva collection device and kit to obtain and transport dried saliva samples cheaply and safely. The device consists of a special paper-based ...

022

FluiDx-AD @fluidx-ad.bsky.social · 06/10/2025

Ahead of @alzheimereurope.bsky.social #35AEC Bologna: members of the European Working Group of People with Dementia & the European Dementia Carers Working Group are consulting on @fluidx-ad.bsky.social prototype saliva-based screening tests for Alzheimer’s disease risk indication. www.fluidx-ad.eu

063

FluiDx-AD @fluidx-ad.bsky.social · 19/09/2025

Anti-amyloid therapies cause ARIA in a subset of patients. We are working on blood-based biomarkers & a whole-blood ex vivo assay to help identify who may benefit and who may be at higher risk, supporting eligibility assessment & monitoring. www.fluidx-ad.eu #WorldAlzMonth #WAM2025

000

FluiDx-AD @fluidx-ad.bsky.social · 18/09/2025

Accessible, low-burden testing matters. FluiDx-AD is working towards validation of saliva and plasma biomarkers as well as automated workflows that fit routine clinics, with documentation to support future regulatory steps. www.fluidx-ad.eu #WorldAlzMonth #WAM2025

010

FluiDx-AD @fluidx-ad.bsky.social · 17/09/2025

“Low-cost & simple” matters when you are waiting for answers. Earlier diagnosis helps people plan, seek support, and know what to expect. We aim to evaluate a three-test approach using saliva & blood biomarkers to support earlier, reliable decisions. #WorldAlzMonth #WAM2025 www.fluidx-ad.eu

010

FluiDx-AD @fluidx-ad.bsky.social · 16/09/2025

Early answers open access to support. FluiDx-AD aims to develop and validate three complementary tests: saliva risk indication, plasma confirmation, and a whole blood ex-vivo assay for ARIA risk to guide therapy decisions. #WorldAlzMonth #WAM2025 #WorldAlzheimersMonth www.fluidx-ad.eu

010

FluiDx-AD @fluidx-ad.bsky.social · 15/09/2025

Early, reliable answers help families plan. FluiDx-AD aims to develop & validate three complementary, minimally invasive tests (saliva-based risk indication, plasma-based confirmatory biomarkers, & an assay for ARIA assessment). www.fluidx-ad.eu #WorldAlzMonth #WAM2025

010

FluiDx-AD @fluidx-ad.bsky.social · 12/09/2025

In FluiDx-AD, we aim to develop & validate a trio of saliva- and blood-based tests to support earlier detection, precise confirmation, and ARIA risk assessment for therapy decisions. More information: www.fluidx-ad.eu #WorldAlzheimersMonth #WAM2025 #WorldAlzMonth

010

FluiDx-AD @fluidx-ad.bsky.social · 11/09/2025

People may have to wait far too long for an Alzheimer’s disease diagnosis. FluiDx-AD aims to shorten diagnostic pathways by developing & standardising fluid-based biomarker tests. linktr.ee/FluiDx_AD #WorldAlzheimersMonth #WAM2025 #WorldAlzMonth

011

FluiDx-AD @fluidx-ad.bsky.social · 22/07/2025

🧠On #WorldBrainDay #WBD2025 we highlight FluiDx-AD, improving early Alzheimer’s diagnosis with saliva & blood-based tests. Led by Oslo University Hospital & Pre Diagnostics, with Alzheimer Europe leading on communication & Public Involvement. 🎥 vimeo.com/1058971988 🔗 linktr.ee/FluiDx_AD

vimeo.com

FluiDx-AD - A novel test trio to detect peptide biomarkers in saliva and blood for enhanced diagnosis and management of AD

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither…

011

FluiDx-AD @fluidx-ad.bsky.social · 03/06/2025

The AI-Mind project builds AI tools to scan brain connectivity and predict dementia risk, giving clinicians earlier insight. Horizon Europe spin-off @fluidx-ad.bsky.social proves the impact. Details in Alzheimer Europe's Dementia in Europe Magazine supplement www.alzheimer-europe.org/sites/defaul...

alzheimer-europe.org

010

FluiDx-AD @fluidx-ad.bsky.social · 10/04/2025

A new study shows a saliva test outperforms current blood tests in predicting prostate cancer risk. @fluidx-ad.bsky.social aims to do the same for #Alzheimer’s, with SalivaDx-AD enabling easy at-home risk detection. www.alzheimer-europe.org/our-work/cur... www.theguardian.com/society/2025...

theguardian.com

At-home saliva test for prostate cancer better than blood test, study suggests

Researchers say ‘relatively simple, inexpensive’ means of assessing genetic risk offers hope of better screening

010

FluiDx-AD @fluidx-ad.bsky.social · 17/03/2025

The new Alzheimer Europe Dementia in Europe Magazine features an interview with our Scientific Coordinator Erik Christensen, putting a spotlight on the novel test trio to detect peptide biomarkers for enhanced diagnosis & management of #Alzheimer's disease ⤵️ www.alzheimer-europe.org/sites/defaul...

011

FluiDx-AD @fluidx-ad.bsky.social · 05/03/2025

@fluidx-ad.bsky.social is set to improve #Alzheimer’s disease diagnosis with minimally invasive, cost-effective saliva & blood tests. Learn more: alzheimereurope.newsweaver.com/ConferenceAn... www.vimeo.com/1058971988

011